Helptext

Movies



Company Information

Company NameOncology Venture Sweden AB
Company Idea

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

Phone+45 21 70 10 49CEOPeter Buhl Jensen
E-mailinfo(snabel-a)oncologyventure(punkt)comChairm. of the BoardDuncan Moore
Homepagehttp://www.oncologyventure.com 

Instrument Information

Full NameOncology VentureShort NameOV
No of shares10,877,007Par Value0.14 SEK
TypeShareISIN codeSE0007157409

Price Information

+/-(0.50)
%-1.64
Latest29.90
High30.10
Low29.30
Volume5,970
Turnover (SEK)177,203
Market Cap (MSEK)325

Orders

VolumeBidAskVolume
50029.5029.90672
15329.4030.00744
21129.3030.40500
78729.2030.501,050
35029.0031.0075
17528.8032.00200
22528.7032.30341
50028.5034.40130
20028.3034.501,869
45928.1034.80500
25028.0036.00630
1,80027.6039.00500
1,20025.1041.10500
  43.50350
  44.0090
  47.80600

Deals

TimeBuyerSellerPriceVolume
4:26 PMAVAMLI29.9010
4:02 PMAVASWB30.0042
4:02 PMAVANON29.7058
4:02 PMNONSWB29.60400
4:01 PMMLINON29.701,042
3:50 PMAVAMLI30.00100
3:42 PMNRDMLI30.00175
3:37 PMNRDMLI30.00258
3:37 PMNRDAVA29.90310
3:37 PMNRDNON29.90100

Scheduled Reports

DateReport
2017-08-25Halvårsrapport
2017-11-23Delårsrapport tre
2018-02-09Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se